PET-MRI scan test for aggressive brain tumors in children
Part of Cancer clinical trials.
This early-phase study uses a special PET scan plus MRI to help doctors tell apart tumor changes in children with aggressive gliomas. It may help find whether treatment is working or if the tumor is progressing, while also mapping tumor activity in the brain.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child) have an aggressive brain tumor diagnosis: grade III–IV glioma, or DMG/DIPG when MRI looks typical
- There is a measurable tumor area that is at least 1 by 1 cm
- You are between 2 and 20 years old when joining the study
- You can stay well enough for the study (expected survival more than 8 weeks)
- You are able to safely complete MRI/PET scan procedures (may not work if imaging isn’t tolerable for you)
- You are not pregnant or breastfeeding, and you can avoid extra sedation/anesthesia beyond standard care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests how well a special PET-MRI scan (using a radioactive tracer) can find and measure low-grade brain tumors. It may help doctors better track these tumors while you start or continue treatment.
This early-phase study uses special PET/MRI scans to look at how a newly diagnosed high-grade glioma is changing under standard treatment. The goal is to see whether these scans can better assess the disease, which may help guide future care.
This trial tests whether a special PET scan can tell the difference between actual tumor growth and treatment-related changes in people with aggressive brain cancer (high-grade glioma). If you have had radiation and an MRI shows a growing lesion, this study may help clarify the cause.
This study uses special scans (PET and MRI) to look at brain tumors in more detail. It aims to understand tumor metabolism and oxygen levels, which may help guide treatment.
This Phase 1 study tests a new type of MRI scan using a special “hyperpolarized” imaging agent to help doctors diagnose glioma (a type of brain tumor). It’s mainly focused on whether the scan can safely and clearly show tumor-related information in people who may need treatment.
This trial tests a special PET scan tracer (18F-FET) to see if it can help doctors better identify and plan treatment for brain tumors. It may be an option if you are scheduled for surgery for a suspected new glioma.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.